A detailed history of Nisa Investment Advisors, LLC transactions in Savara Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 13 shares of SVRA stock, worth $43. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 86 84.88%
Holding current value
$43
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$3.96 - $5.07 $289 - $370
-73 Reduced 84.88%
13 $0
Q2 2024

Jul 19, 2024

BUY
$3.66 - $5.34 $113 - $165
31 Added 56.36%
86 $0
Q1 2024

May 01, 2024

BUY
$4.19 - $5.59 $230 - $307
55 New
55 $0

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $383M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.